A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7-Reference-Cited by-同舟云学术

A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7

Published:2002-05-21 Issue:11 Volume:99 Page:7669-7674
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Nishikawa K.,Matsuoka K.,Kita E.,Okabe N.,Mizuguchi M.,Hino K.,Miyazawa S.,Yamasaki C.,Aoki J.,Takashima S.,Yamakawa Y.,Nishijima M.,Terunuma D.,Kuzuhara H.,Natori Y.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference24 articles.

1. Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype

2. Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections

3. The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coli

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A tailored tetravalent peptide displays dual functions to inhibit amyloid β production and aggregation;Communications Biology;2023-04-08

2. Therapeutic Options for Diarrheagenic Escherichia coli;Trending Topics in Escherichia coli Research;2023

3. Biochemical and crystallographic assessments of the effect of 4,6‐ O ‐disulfated disaccharide moieties in chondroitin sulfate E on chondroitinase ABC I activity;The FEBS Journal;2022-12-07

4. Development of a novel tetravalent peptide that absorbs subtilase cytotoxin by targeting the receptor-binding B-subunit;Biochemical and Biophysical Research Communications;2022-11

5. Host Cellular Response during Enterohaemorrhagic Escherichia coli Shiga Toxin Exposure;Microbiology and Biotechnology Letters;2022-10-25